Welcome to the Michigan Center for Translational Pathology. At MCTP, we are committed to the discovery of the genetic factors involved in the development of a wide variety of diseases, including prostate cancer, breast cancer, lung cancer, colon cancer, and skin cancer, among others. We actively pursue advances in the early detection and treatment of various types of cancer and other diseases, with the eventual goal of creating new targeted therapies.

The landmark investigations of our research team, under the leadership of Dr. Arul Chinnaiyan, revealed the probable origins of prostate cancer; and this was just the beginning of our unprecedented, creative approach to unlock the secrets of disease development hidden within the human genome. By combining cutting-edge research techniques in areas such as genomics, proteomics, coupled with innovative bioinformatics techniques and high-throughput analysis for identification of critical biomarkers, we tackle the mysteries of disease development and open the doorway of discovery for the treatment of human disease.

So whether you are a member of the general public, scientific community, or news media, we strive to keep you informed of the latest advances by our team of dedicated research and physician scientists. Come join us in this challenge as you explore the groundbreaking research underway at MCTP!